Pinter Matthias, Hucke Florian, Zielonke Nadine, Trauner Michael, Sieghart Wolfgang, Peck-Radosavljevic Markus
Division of Gastroenterology and Hepatology and Comprehensive Cancer Center, AKH and Medical University of Vienna, Vienna, Austria.
Dig Dis. 2014;32(6):664-9. doi: 10.1159/000367983. Epub 2014 Oct 29.
BACKGROUND/AIMS: The heterogeneous epidemiology of hepatocellular carcinoma (HCC) with the highest incidence rates in East Asia, sub-Saharan Africa and Melanesia results from variations in the main risk factors. We investigated epidemiological trends, including incidence and mortality, of patients diagnosed with HCC over a 20-year period in Austria.
Data on age-adjusted incidence rates of HCC were obtained from the Austrian National Cancer Registry, which compiles nationwide data on all newly diagnosed cancers. Data on age-adjusted mortality were obtained from the national death registry (Statistics Austria).
Of 24,939 patients diagnosed with hepatobiliary tumors between 1990 and 2009, 8,561 subjects had HCC (m/f ratio 75/25%; mean age 69 years). Lymph node and distant metastases were present in 7.5 and 12.2%, respectively. The age-adjusted incidence rate was significantly higher in men than women (m/f ratio 4.5/1) and markedly increased in men (4.68/5.10) but remained stable in women (1.18/1.11). Similarly, the age-adjusted mortality rate was significantly higher in men than women (m/f ratio 4.5/1), increased in men (4.02/4.98) and remained stable in women (0.92/1.0). The median overall survival was 4.5 months for men and 3.2 months for women with 1-/5-year survival rates of 33/11% and 28/10%, respectively.
HCC is the most common hepatobiliary neoplasia in Austria and has a very poor prognosis. The age-adjusted incidence and mortality rates were higher in males, increased over time in men and remained stable in women. Extrahepatic metastases were rarely diagnosed and associated with dismal survival.
背景/目的:肝细胞癌(HCC)在东亚、撒哈拉以南非洲和美拉尼西亚发病率最高,其流行病学存在异质性,这是由主要危险因素的差异导致的。我们调查了奥地利20年间诊断为HCC患者的流行病学趋势,包括发病率和死亡率。
HCC年龄调整发病率数据来自奥地利国家癌症登记处,该登记处汇编全国所有新诊断癌症的数据。年龄调整死亡率数据来自国家死亡登记处(奥地利统计局)。
1990年至2009年间诊断为肝胆肿瘤的24939例患者中,8561例为HCC(男/女比例75/25%;平均年龄69岁)。淋巴结转移和远处转移分别占7.5%和12.2%。男性年龄调整发病率显著高于女性(男/女比例4.5/1),男性发病率显著上升(4.68/5.10),而女性保持稳定(1.18/1.11)。同样,男性年龄调整死亡率显著高于女性(男/女比例4.5/1),男性死亡率上升(4.02/4.98),女性保持稳定(0.92/1.0)。男性的中位总生存期为4.5个月,女性为3.2个月,1年/5年生存率分别为33%/11%和28%/10%。
HCC是奥地利最常见的肝胆肿瘤,预后很差。年龄调整发病率和死亡率男性更高,男性随时间增加,女性保持稳定。肝外转移很少被诊断出来,且与生存率低相关。